Key statistics
On Friday, X T L Biopharmaceuticals Ltd (H2K2:FRA) closed at 0.705, 58.78% above the 52 week low of 0.444 set on Jan 02, 2026.
52-week range
| Open | 0.685 |
|---|---|
| High | 0.705 |
| Low | 0.685 |
| Bid | 0.695 |
| Offer | 0.805 |
| Previous close | 0.66 |
| Average volume | 20.00 |
|---|---|
| Shares outstanding | 9.46m |
| Free float | 9.37m |
| P/E (TTM) | -- |
| Market cap | 8.62m USD |
| EPS (TTM) | -0.73 USD |
Data delayed at least 15 minutes, as of Feb 13 2026 19:26 GMT.
More ▼
Announcements
- XTL Update on Recent Developments
- XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
- XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
- XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- XTL Names Mr. Noam Band as its New Chief Executive Officer
More ▼
